Guided Therapeutics (GTHP) EBT Margin Growth (1y) (2011 - 2025)
Guided Therapeutics (GTHP) EBT Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 165.00 |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | -6.40 Mn |
| Mar 31, 2024 | -275,000.00 |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 619,000.00 |
| Sep 30, 2022 | -3.71 Mn |
| Jun 30, 2022 | 3.32 Mn |
| Dec 31, 2021 | -940,400.00 |
| Sep 30, 2021 | -168,756.00 |
| Dec 31, 2020 | 189,525.00 |
| Sep 30, 2020 | 1.46 Mn |
| Dec 31, 2019 | 1.33 Mn |
| Sep 30, 2019 | 2.47 Mn |
| Jun 30, 2019 | -30.91 Mn |
| Mar 31, 2019 | -2.82 Mn |
| Dec 31, 2018 | 163,591.00 |
| Sep 30, 2018 | -3.01 Mn |
| Jun 30, 2018 | 4.40 Mn |
| Mar 31, 2018 | 2.76 Mn |
| Dec 31, 2017 | -857,807.00 |